| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Jun 19, 2024 | Azelby Robert Dir | Sell | Adc Therapeutics Sa | ADCT | $2.89 | $20,216 | -11.66% |
| Feb 12, 2018 | Feb 16, 2018 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $85.55 | $355,802 | -4.44% |
| Feb 12, 2018 | Feb 15, 2018 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $85.55 | $355,631 | -4.43% |
| Feb 08, 2018 | Feb 10, 2018 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $85.77 | $299,938 | -3.60% |
| Feb 01, 2018 | Feb 03, 2018 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $85.78 | $357,445 | -4.14% |
| Jan 22, 2018 | Jan 24, 2018 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $86.25 | $9M | -59.14% |
| Jan 17, 2018 | Jan 20, 2018 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $68.61 | $2M | -29.14% |
| Dec 18, 2017 | Dec 20, 2017 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $44.96 | $81,647 | -2.50% |
| Nov 02, 2017 | Nov 03, 2017 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $54.95 | $366,297 | -8.33% |
| Sep 13, 2017 | Sep 14, 2017 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $44.95 | $577,608 | -25.55% |
| Aug 29, 2017 | Aug 31, 2017 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $39.95 | $514,117 | -20.38% |
| Nov 10, 2016 | Nov 11, 2016 | Azelby Robert EVP Chief Commercial Officer | Sell | Juno Therapeutics, Inc. | JUNO | $24.14 | $311,848 | -26.56% |